Expert Radar
Dr. Haifaa Abdulhaq, MD
Dr. Haifaa Abdulhaq, MD
Hematologist and Oncologist, Community Regional Medical Center (Fresno, CA)
Doctor of Medicine, Damascus University Faculty of Medicine
Dr. Haifaa Abdulhaq has over 15 years of experience in the field of Hematology & Oncology. She earned her MD from Damascus University Faculty of Medicine. After completing her internship and residency in Internal Medicine at West Penn Hospital, she went on to complete a fellowship in Hematology & Oncology at West Penn Hospital. Today, this expert is board-certified in Hematology, Medical Oncology, and Internal Medicine. Currently, she serves as a Clinical Professor of Hematology and Oncology and as a Director of the Hematology/Oncology Fellowship Program at UCSF Fresno.
h*********@******.ucsf
(559) ***-****
Clovis, California
Get a FREE Demo of Dr. Haifaa Abdulhaq, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
52
Media & News
223
Social Media Mentions
86
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|
Unlock Dr. Haifaa Abdulhaq, MD's full profile
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 52 records
Title | Type |
|---|---|
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm | Review |
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial | Journal Article |
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 223 records
Title | Description |
|---|---|
UCSF Lymphoma Clinical Trials — San Francisco Bay Area | Nov 27, 2024 ----- This is a single arm open-label multicenter phase I/II investigation ... Rangaswami Haifaa Abdulhaq , MD Lena E. Winestone C. Babis Andreadis ... |
Welcome to THE HEME TEAM's Fundraising Page | Jul 27, 2024 ----- Karina Ibarra Haifaa Abdulhaq Stephanie M Harrah Timothy ... Abdulhaq and Korina and all the wonderful people at Clovis Community Cancer ... |
Targeted Oncology Staff | Page 2 | ... Oncology CME/CE ... During a Case-Based Roundtable event, Haifaa Abdulhaq ... KEYNOTE -859 Outcomes Influence NCCN Guidelines on Pembrolizumab in Upper GI Cancer . |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
Damascus University Faculty of Medicine | Doctor of Medicine |
Work History
Title | Employer |
|---|---|
Hematologist and Oncologist | Community Regional Medical Center (Fresno, CA) |
Physician | Saint Agnes Medical Center (Fresno, CA) |
— | West Penn Hospital (Pittsburgh, PA) |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3–5 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
